One possible explanation could be given by the hypothesis that the GP Ia rs1126643 polymorphism does not influence development of coronary atherosclerosis as such but might lead to increased platelet thrombogenicity, therefore leading to ischemic events primarily in younger patients without significant CAD (17). This evidence concerns the gene ITGA2 and coronary artery disorder.